Insulin nanoparticles for transdermal delivery: Preparation and physicochemical characterization and in vitro evaluation

Drug Development and Industrial Pharmacy

Volumn 36, Issue 10, 2010, Pages 1177-1185

  Zhao, Xiuhua ^a   Zu, Yuangang ^a   Zu, Shuchong ^a   Wang, Dan ^a   Zhang, Ying ^a   Zu, Baishi ^a  

^a NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

Insulin; Nanoparticles; Physicochemical characterization; Preparation; Transdermal delivery

Indexed keywords

INSULIN; NANOPARTICLE;

ANIMAL TISSUE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; FEMALE; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RAT; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRY; X RAY DIFFRACTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; DIMETHYL SULFOXIDE; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; FEMALE; HYPOGLYCEMIC AGENTS; INSULIN; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; RATS; RATS, WISTAR; SKIN ABSORPTION; SOLUBILITY; THERMODYNAMICS; THERMOGRAVIMETRY;

EID: 77956412846     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639041003695089     Document Type: Article

References (20)

1. Gale EAM. (2009). The discovery of type 1 diabetes. Diabetes, 50(2):217-26.
2. Vivian Fonseca M. (2006). The role of basal insulin therapy in patients with type 2 diabetes mellitus. Insulin, 1(2):51-60.
3. Chen H, Zhu H, Zheng J, Mou D, Wan J, Zhang J, et al. (2009). Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J Control Release, 139(1):63-72.
4. Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, et al. (2005). Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: A 6-month, randomized, comparative trial. Diab Care, 28(7):1630-5.
5. Klingler C, Müller BW, Steckel H. (2009). Insulin-micro- and nanoparticles for pulmonary delivery. Int J Pharm, 377(1-2): 173-9.
6. Singh B, Chauhan N. (2009). Modification of psyllium polysaccharides for use in oral insulin delivery. Food Hydrocolloid, 23(3):928-35.
7. Lee Y-C, Simamora P, Pinsuwanc S, Yalkowskya SH. (2002). Review on the systemic delivery of insulin via the ocular route. Int J Pharm, 233(1-2):1-18.
8. Hosny EA (1999). Relative hypoglycemia of rectal insulin suppositories containing deoxycholic acid, sodium taurocholate, polycarbophil, and their combinations in diabetic rabbits. Drug Dev Ind Pharm, 25(6):745-52.
9. El-Sayed Khafagy MM, Onukia Y, Takayamaa K. (2007). Current challenges in non-invasive insulin delivery systems: A comparative review. Adv Drug Deliv Rev, 59(15):1521-46.
10. Prausnitz MR, Mitragotri S, Langer R. (2004). Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov, 3(2):115-24. (Pubitemid 38239773)
11. Prausnitz MR, Mitragotri S, Langer R. (2001). Overcoming skins barrier: The search for effective and user-friendly drug delivery. Diab Technol Ther, 3(2):233-6.
12. El Maghraby GM, Williams AC, Barry BW. (2004). Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm, 276(1-2):143-61.
13. Kalia YN, Naik A, Garrison J, Guy RH. (2004). Iontophoretic drug delivery. Drug Deliv, 56(5):619-58.
14. Lavon I, Kost J. (2004). Ultrasound and transdermal drug delivery. Drug Discov Today, 9(15):670-6.
15. Prausnitz MR. (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv, 56(5):581-7.
16. Reverchon E, Adami R. (2006). Nanomaterials and supercritical fluids. J Supercrit Fluids, 37(1):1-22.
17. Miguel AMF, Gamse T, Cocero MJ. (2006). Supercritical antisolvent precipitation of lycopene: Effect of the operating parameters. J Supercrit Fluids, 36(3):225-35.
18. Catchpole OJ, Grey JB, Mitchell KA, Lan JS. (2004). Supercitical antisolvent fractionation of propolis tincture. J Supercrit Fluids, 29(1-2):97-106.
19. Zhiyi L, Jingzhi J, Xuewu L, Huihua T, Wei W. (2009). Experimental investigation on the micronization of aqueous cefadroxil by supercritical fluid technology. J Supercrit Fluids, 48(3):247-52.
20. Huang Z, Sun G-B, Chiew YC, Kawi S. (2006). Formation of ultrafine aspirin particles through rapid expansion of supercritical solutions (RESS). Powder Technol, 160(2): 127-34.